In regulated markets like healthcare, a working product isn’t enough — startups must also figure out who pays, how adoption happens, and what to prove before scaling.
For decades, Silicon Valley has followed this startup playbook — move fast, find product-market fit, and scale. For software companies selling directly to consumers or other businesses, that approach works. But when a startup sells into a regulated industry or a large institution, the rules change.
Healthcare is the clearest example. A company can build an impressive product, demonstrate it works, and still struggle to turn it into a viable business. Regulatory requirements, purchasing processes, reimbursement challenges, and workflows can all stand between promising technology and widespread adoption.
The same challenges exist across industries like financial services, education, and government. In these markets, building a product is only one part. Founders must also understand who needs it, pays for it, and what it takes to get an organization to change how it operates.
Venture capital has historically gravitated toward software for good reason. Once a product works, serving additional customers often requires relatively little incremental investment. Companies can test features, respond to feedback, and expand without rebuilding their business at every stage.
Institutional markets operate differently. Sales cycles can stretch for months or years. Products require regulatory approval, third-party validation, security reviews, or integration with existing systems before customers can use them. Even when an organization recognizes a problem, the person experiencing it may not control the purchasing decision.
Founders need to ask different questions — What must we prove before customers will trust this product?
Source link







